Refine Your Results

Click below to filter your search results

Search Results

Return to List
Results 141–160 of 223
Title Date
141.

Ovarian Reserve Testing

Number 618

ABSTRACT The main goal of ovarian reserve testing is to identify those individuals who are at risk of decreased or diminished ovarian reserve commonly known as DOR Although ovarian reserve testing cannot predict the end of ones reproductive years results outside the range expected for a patients a...

January 2015

PDF Format
142.

Over-the-Counter Access to Oral Contraceptives

Number 544

(Reaffirmed 2014)

ABSTRACT Unintended pregnancy remains a major public health problem in the United States Access and cost issues are common reasons why women either do not use contraception or have gaps in use A potential way to improve contraceptive access and use and possibly decrease unintended pregnancy rates ...

December 2012

PDF Format
143.

Pain Relief During Labor

Number 295

(Reaffirmed 2008, Replaces No. 231, February 2000)

ABSTRACT Pain management should be provided whenever medically indicated The American Society of Anesthesiologists ASA and the American College of Obstetricians and Gynecologists ACOG believe that women requesting epidural analgesia during labor should not be deprived of this service based on thei...

July 2004

PDF Format
144.

Partner Consent for Participation in Women's Reproductive Health Research

Number 307

(Reaffirmed 2008)

ABSTRACT Recent advances in reproductive medicine include treatment of subfertility as well as investigation of agents that may serve as both contraceptives and potential prophylaxis against sexually transmitted diseases including potential protection from human immunodeficiency virus HIV Although...

December 2004

PDF Format
145.

Partnering With Patients to Improve Safety

Number 490

(Reaffirmed 2013, Replaces No. 320, November 2005)

ABSTRACT Actively involving patients in the planning of health services is recommended as a means of improving the quality of care This can increase patient engagement and reduce risk resulting in improved outcomes satisfaction and treatment adherence Introduction The foundation for a positive phy...

May 2011

PDF Format
146.

Patient Safety and Health Information Technology

Number 621

(Replaces Committee Opinion Number 472, November 2010)

ABSTRACT The advantages of health information technology IT include facilitating communication between health care providers improving medication safety tracking and reporting and promoting quality of care through optimized access to and adherence to guidelines Health IT systems permit the collect...

January 2015

PDF Format
147.

Patient Safety in Obstetrics and Gynecology

Number 447

(Reaffirmed 2012, Replaces No. 286, October 2003)

ABSTRACT Since publication of the Institute of Medicines landmark report To Err is Human Building a Safer Health System emphasis on patient safety has steadily increased Obstetriciangynecologists should continuously incorporate elements of patient safety into their practices and also encourage oth...

December 2009

PDF Format
148.

Patient Safety in the Surgical Environment

Number 464

(Reaffirmed 2014, Replaces No. 328, February 2006)

ABSTRACT Ensuring patient safety in the operating room begins before the patient enters the operative suite and includes attention to all applicable types of preventable medical errors including for example medication errors but surgical errors are unique to this environment Steps to prevent wrong...

September 2010

PDF Format
149.

Patient Testing Ethical Issues in Selection and Counseling

Number 363

(Reaffirmed 2012)

ABSTRACT Recommendations to patients about testing should be based on current medical knowledge a concern for the patients best interests and mutual consultation In addition to establishing a diagnosis testing provides opportunities to educate inform and advise The ethical principles of respect fo...

April 2007

PDF Format
150.

Performance Enhancing Anabolic Steroid Abuse in Women

Number 484

(Reaffirmed 2013)

ABSTRACT Anabolic steroids are composed of testosterone and other substances related to testosterone that promote growth of skeletal muscle increase hemoglobin concentration and mediate secondary sexual characteristics These substances have been in use since the 1930s to promote muscle growth impr...

April 2011

PDF Format
151.

Perinatal Risks Associated With Assisted Reproductive Technology

Number 324

(Reaffirmed 2007)

ABSTRACT Over the past two decades the use of assisted reproductive technology ART has increased dramatically worldwide and has made pregnancy possible for many infertile couples A growing body of evidence suggests an association between pregnancies resulting from ART and perinatal morbidity possi...

November 2005

PDF Format
152.

Personalized Genomic Testing for Disease Risk

Number 527

(Reaffirmed 2014)

ABSTRACT Advances in genetic technologies have led to the identification of hundreds of single nucleotide polymorphisms that are associated with a variety of complex diseases including cancer diabetes cardiovascular disease and Alzheimer disease Although personalized genomic tests that provide inf...

June 2012

PDF Format
153.

Pharmacogenetics

Number 488

(Reaffirmed 2015)

ABSTRACT Pharmacogenetics is the study of genetic variations in drug response that are determined by specific genes It is hoped that the use of pharmacogenetics in clinical practice may improve drug safety and decrease the rate of adverse drug reactions Given the potential applications of pharmaco...

May 2011

PDF Format
154.

Placenta Accreta

Number 529

(Reaffirmed 2014)

ABSTRACT Placenta accreta is a potentially lifethreatening obstetric condition that requires a multidisciplinary approach to management The incidence of placenta accreta has increased and seems to parallel the increasing cesarean delivery rate Women at greatest risk of placenta accreta are those w...

July 2012

PDF Format
155.

Planned Home Birth

Number 476

(Reaffirmed 2013)

ABSTRACT Although the Committee on Obstetric Practice believes that hospitals and birthing centers are the safest setting for birth it respects the right of a woman to make a medically informed decision about delivery Women inquiring about planned home birth should be informed of its risks and ben...

February 2011

PDF Format
156.

Postmenopausal Estrogen Therapy: Route of Administration and Risk of Venous Thromboembolism

Number 556

ABSTRACT The development of menopausal symptoms and related disorders which lead women to seek prescriptions for postmenopausal estrogen therapy and hormone therapy is a common reason for a patient to visit her gynecologist but these therapies are associated with an increased risk of venous thromb...

April 2013

PDF Format
157.

Preconception and Prenatal Carrier Screening for Genetic Diseases in Individuals of Eastern European Jewish Descent

Number 442

(Reaffirmed 2014, Replaces No. 298, August 2004)

ABSTRACT Certain autosomal recessive disease conditions are more prevalent in individuals of Eastern European Jewish Ashkenazi descent Previously the American College of Obstetricians and Gynecologists recommended that individuals of Eastern European Jewish ancestry be offered carrier screening fo...

October 2009

PDF Format
158.

Predispute, Voluntary, Binding Arbitration

Number 583

ABSTRACT Arbitration is a form of dispute resolution that is an alternative to taking a case to court Weighing the potential advantages and disadvantages predispute arbitration may represent a valid alternative dispute resolution strategy for physicians and patients When correctly prepared contrac...

January 2014

PDF Format
159.

Preexposure Prophylaxis for the Prevention of Human Immunodeficiency Virus

Number 595

Abstract Preexposure prophylaxis is defined as the administration of antiretroviral medications to individuals who are not infected with human immunodeficiency virus HIV and are at the highest risk of acquiring HIV infection In combination with other proven HIVprevention methods preexposure prophy...

May 2014

PDF Format
160.

Preimplantation Genetic Screening for Aneuploidy

Number 430

(Reaffirmed 2014)

ABSTRACT Preimplantation genetic screening differs from preimplantation genetic diagnosis for single gene disorders and was introduced for the detection of chromosomal aneuploidy Current data does not support a recommendation for preimplantation genetic screening for aneuploidy using fluorescence ...

March 2009

PDF Format

American Congress of Obstetricians and Gynecologists
409 12th Street SW, Washington, DC  20024-2188 | Mailing Address: PO Box 70620, Washington, DC 20024-9998